Resistance to first-line antibiotic therapy among patients with uncomplicated acute cystitis in Melbourne, Australia: prevalence, predictors and clinical impact
- PMID: 38161965
- PMCID: PMC10753919
- DOI: 10.1093/jacamr/dlad145
Resistance to first-line antibiotic therapy among patients with uncomplicated acute cystitis in Melbourne, Australia: prevalence, predictors and clinical impact
Abstract
Background: Australian guidelines recommend trimethoprim or nitrofurantoin as first-line agents for uncomplicated urinary tract infections (UTIs). Laboratory surveillance indicates high rates of trimethoprim resistance among urinary bacterial isolates, but there are scant local clinical data about risk factors and impact of trimethoprim resistance.
Objectives: To determine the prevalence, risk factors, mechanism and impact of resistance to first-line antibiotic therapy for uncomplicated UTIs in the community setting.
Methods: A prospective observational study from October 2019 to November 2021 in four general practices in Melbourne, Australia. Female adult patients prescribed an antibiotic for suspected or confirmed uncomplicated acute cystitis were eligible. Primary outcome was urine isolates with resistance to trimethoprim and/or nitrofurantoin.
Results: We recruited 87 participants across 102 UTI episodes with median (IQR) age of 63 (47-76) years. Escherichia coli was the most common uropathogen cultured (48/62; 77%); 27% (13/48) were resistant to trimethoprim (mediated by a dfrA gene) and none were resistant to nitrofurantoin. Isolates with resistance to a first-line therapy were more common among patients reporting a history of recurrent UTIs [risk ratio (RR): 2.08 (95% CI: 1.24-3.51)] and antibiotic use in the previous 6 months [RR: 1.89 (95% CI: 1.36-2.62)]. Uropathogen resistance to empirical therapy was not associated with worse clinical outcomes.
Conclusions: Resistance to trimethoprim is common in uncomplicated UTIs in Australia but may not impact clinical outcomes. Further research is warranted on the appropriateness of trimethoprim as empirical therapy, particularly for patients with antimicrobial resistance risk factors.
© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Figures
Similar articles
-
Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.Antimicrob Resist Infect Control. 2023 Aug 1;12(1):73. doi: 10.1186/s13756-023-01282-4. Antimicrob Resist Infect Control. 2023. PMID: 37528415 Free PMC article.
-
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care.J Antimicrob Chemother. 2006 Nov;58(5):1000-8. doi: 10.1093/jac/dkl368. Epub 2006 Sep 23. J Antimicrob Chemother. 2006. PMID: 16998209
-
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.J Antimicrob Chemother. 2014 Dec;69(12):3259-62. doi: 10.1093/jac/dku282. Epub 2014 Jul 25. J Antimicrob Chemother. 2014. PMID: 25063776
-
Antibiotic Resistance Among Uropathogenic Escherichia coli.Pol J Microbiol. 2019 Dec;68(4):403-415. doi: 10.33073/pjm-2019-048. Epub 2019 Dec 5. Pol J Microbiol. 2019. PMID: 31880885 Free PMC article. Review.
-
Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance.Mayo Clin Proc. 2004 Aug;79(8):1048-53; quiz 1053-4. doi: 10.4065/79.8.1048. Mayo Clin Proc. 2004. PMID: 15301333 Review.
Cited by
-
Trends in the Prevalence of Antimicrobial Resistance in Escherichia coli Isolated from Outpatient Urine Cultures in French Amazonia.Am J Trop Med Hyg. 2024 Jun 25;111(2):287-296. doi: 10.4269/ajtmh.23-0887. Print 2024 Aug 7. Am J Trop Med Hyg. 2024. PMID: 38917783 Free PMC article.
-
SWOT and Root Cause Analyses of Antimicrobial Resistance to Oral Antimicrobial Treatment of Cystitis.Antibiotics (Basel). 2024 Apr 4;13(4):328. doi: 10.3390/antibiotics13040328. Antibiotics (Basel). 2024. PMID: 38667004 Free PMC article. Review.
References
-
- Britt H, Miller GC, Henderson J et al. General Practice Activity in Australia 2015–16. Sydney University Press, 2016.
-
- Jarvis TR, Chan L, Gottlieb T. Assessment and management of lower urinary tract infection in adults. Aust Prescr 2014; 37: 7–9. 10.18773/austprescr.2014.002 - DOI
-
- OUTBREAK consortium . A One Health antimicrobial resistance economic perspective. 2020. https://outbreakproject.com.au/wp-content/uploads/2020/12/OUTBREAK_REPOR....
LinkOut - more resources
Full Text Sources